Effects of COVID-19 vaccination type and vaccination-infection interval on viral clearance dynamics in Omicron BA.5 patients at Guangzhou Fangcang shelter hospitals: A propensity score matched multicenter retrospective cohort study
4 affiliations
- 1Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
- 2Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong, China
- 3Shenzhen Health Development Research and Data Management Center, Shenzhen, Guangdong, China
- 4Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
Abstract
The Omicron BA.5 subvariant exhibited pronounced immune evasion and was associated with widespread breakthrough infections. Unlike settings where mRNA vaccines predominated, China mainly used inactivated vaccines, with the adenovirus type 5-vectored vaccine Ad5-nCoV also administered at scale. Real-world evidence on post-infection viral clearance associated with these platforms remains limited. This multicenter retrospective cohort study enrolled 16,533 mild or asymptomatic Omicron BA.5 cases from two Fangcang shelter hospitals in Guangzhou, China, from Novernber 5 to December 8, 2022. The primary objective was to compare viral-clearance time between unvaccinated and vaccinated participants. The secondary objective was to compare inactivated-vaccine recipients, or and Ad5-nCoV recipients, containing regimens in a propensity score-matched cohort; the last-dose-to-infection interval analysis was exploratory. Propensity score matching was performed using age, sex, marital status, occupation, and province as covariates to improve between-group comparability. All patients underwent standardized daily RT-PCR testing containing both N and ORF1ab genes, with Ct values > 35 defined as negative. The outcome was time to viral clearance, defined as two consecutive negative nasopharyngeal swabs ≥ 24 hours apart. In the overall cohort, vaccinated patients had significantly shorter shedding duration (9.05 vs… 10.42d; P < .001) compared with unvaccinated patients. The matched cohort included 228 unvaccinated, 228 inactivated vaccine recipients, and 114 Ad5-nCoV recipients. Median time to viral clearance differed across groups with 9.42, 8.56, and 8.48d, respectively. Prior vaccination was associated with shorter viral clearance but with no significant difference observed between inactivated vaccine and Ad5-nCoV recipients among the matched regimens.
Related
- Comparison of Uncovered and Covered Biliary SEMS for the Salvage of Obstructed SEMS: A Multicenter Retrospective Propensity Score–Weighted Study
- The impact of histological subtype on positive surgical margins in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy: a multicenter retrospective cohort study using propensity score matching (the MSUG 94 group)
- Conformal sphincter preservation operation versus modified Bacon operation for ultralow rectal cancer: a multicenter retrospective study using propensity-score matching and inverse probability of treatment weighting
- Association of liberal versus restrictive oxygen saturation targets with mortality in mechanically ventilated stroke patients: a multicenter retrospective propensity-matched analysis
- Comparative effectiveness of total thyroidectomy versus hemithyroidectomy for low-risk differentiated thyroid cancer: a multicenter retrospective cohort study with propensity score matching.
BibTeX
@article{jiang2026effects,
title = {{Effects of COVID-19 vaccination type and vaccination-infection interval on viral clearance dynamics in Omicron BA.5 patients at Guangzhou Fangcang shelter hospitals: A propensity score matched multicenter retrospective cohort study}},
author = {Zhenjie Jiang and Qian Wang and Xuetao Kong and Xiaoling Lin and Dongyu Ma and Faquan Chen and Qiuzhi Cai and Qingwen Sun and Zhigang Deng and Huiqing Zeng and Yuanda Xu},
journal = {Human Vaccines \& Immunotherapeutics},
year = {2026},
month = nov,
doi = {10.1080/21645515.2026.2731694},
url = {https://doi.org/10.1080/21645515.2026.2731694},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Effects of COVID-19 vaccination type and vaccination-infection interval on viral clearance dynamics in Omicron BA.5 patients at Guangzhou Fangcang shelter hospitals: A propensity score matched multicenter retrospective cohort study
AU - Zhenjie Jiang
AU - Qian Wang
AU - Xuetao Kong
AU - Xiaoling Lin
AU - Dongyu Ma
AU - Faquan Chen
AU - Qiuzhi Cai
AU - Qingwen Sun
AU - Zhigang Deng
AU - Huiqing Zeng
AU - Yuanda Xu
PY - 2026
DA - 2026/11/11
JO - Human Vaccines & Immunotherapeutics
DO - 10.1080/21645515.2026.2731694
UR - https://doi.org/10.1080/21645515.2026.2731694
AB - The Omicron BA.5 subvariant exhibited pronounced immune evasion and was associated with widespread breakthrough infections. Unlike settings where mRNA vaccines predominated, China mainly used inactivated vaccines, with the adenovirus type 5-vectored vaccine Ad5-nCoV also administered at scale. Real-world evidence on post-infection viral clearance associated with these platforms remains limited. This multicenter retrospective cohort study enrolled 16,533 mild or asymptomatic Omicron BA.5 cases from two Fangcang shelter hospitals in Guangzhou, China, from Novernber 5 to December 8, 2022. The primary objective was to compare viral-clearance time between unvaccinated and vaccinated participants. The secondary objective was to compare inactivated-vaccine recipients, or and Ad5-nCoV recipients, containing regimens in a propensity score-matched cohort; the last-dose-to-infection interval analysis was exploratory. Propensity score matching was performed using age, sex, marital status, occupation, and province as covariates to improve between-group comparability. All patients underwent standardized daily RT-PCR testing containing both N and ORF1ab genes, with Ct values > 35 defined as negative. The outcome was time to viral clearance, defined as two consecutive negative nasopharyngeal swabs ≥ 24 hours apart. In the overall cohort, vaccinated patients had significantly shorter shedding duration (9.05 vs… 10.42d; P < .001) compared with unvaccinated patients. The matched cohort included 228 unvaccinated, 228 inactivated vaccine recipients, and 114 Ad5-nCoV recipients. Median time to viral clearance differed across groups with 9.42, 8.56, and 8.48d, respectively. Prior vaccination was associated with shorter viral clearance but with no significant difference observed between inactivated vaccine and Ad5-nCoV recipients among the matched regimens.
SN - 2164-5515
SN - 2164-554X
ER -